Emerging roles of microRNAs in intestinal ischemia/reperfusion-induced injury: a review

Ghaidafeh Akbari1

  • 1Medicinal Plants Research Center, Department of Physiology, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran. ghaidafehakbari@yahoo.com.

Insights

MicroRNAs (miRNAs) play a dual role in intestinal ischemia/reperfusion (II/R) injury, with some offering protection and others exacerbating damage. Modulating specific miRNAs may lead to novel therapeutic strategies for II/R injury.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Pathology

Background:

  • Intestinal ischemia/reperfusion (II/R) injury is a critical condition linked to significant morbidity and mortality.
  • This injury arises from various clinical scenarios including shock, trauma, and mesenteric ischemia.
  • MicroRNAs (miRNAs) are key regulators of gene expression with emerging roles in cellular processes.

Purpose of the Study:

  • To review the multifaceted roles of specific miRNAs in the pathogenesis of II/R injury.
  • To explore the potential of miRNA modulation as a therapeutic approach for II/R damage.
  • To correlate miRNA expression changes with key pathological mechanisms in II/R injury.

Main Methods:

  • Comprehensive literature review of scientific articles from 2000-2020.
  • Data sourced from major scientific databases (PubMed, Scopus, Web of Science, etc.).
  • Analysis focused on studies investigating miRNA involvement in II/R injury and related cellular processes.

Main Results:

  • II/R injury significantly alters the expression of various miRNAs, with some upregulated and others downregulated.
  • Changes in miRNA expression correlate with critical pathways including autophagy, inflammation, oxidative stress, apoptosis, and epithelial barrier function.
  • Specific miRNAs demonstrate either protective or detrimental effects in the context of II/R insult.

Conclusions:

  • miRNAs are integral to the molecular mechanisms underlying II/R injury.
  • Targeting specific miRNAs using agomiRs or antagomiRs presents a promising avenue for novel therapeutic interventions.
  • Further research into miRNA-based therapies could revolutionize the treatment of II/R damage.